|
US20060024304A1
(en)
*
|
2000-06-28 |
2006-02-02 |
Gerngross Tillman U |
Immunoglobulins comprising predominantly a Man5GlcNAc2 glycoform
|
|
US7795002B2
(en)
*
|
2000-06-28 |
2010-09-14 |
Glycofi, Inc. |
Production of galactosylated glycoproteins in lower eukaryotes
|
|
US7598055B2
(en)
*
|
2000-06-28 |
2009-10-06 |
Glycofi, Inc. |
N-acetylglucosaminyltransferase III expression in lower eukaryotes
|
|
US7449308B2
(en)
|
2000-06-28 |
2008-11-11 |
Glycofi, Inc. |
Combinatorial DNA library for producing modified N-glycans in lower eukaryotes
|
|
US7863020B2
(en)
|
2000-06-28 |
2011-01-04 |
Glycofi, Inc. |
Production of sialylated N-glycans in lower eukaryotes
|
|
US7029872B2
(en)
*
|
2000-06-28 |
2006-04-18 |
Glycofi, Inc |
Methods for producing modified glycoproteins
|
|
US20060029604A1
(en)
*
|
2000-06-28 |
2006-02-09 |
Gerngross Tillman U |
Immunoglobulins comprising predominantly a GlcNAc2Man3GlcNAc2 glycoform
|
|
US7625756B2
(en)
|
2000-06-28 |
2009-12-01 |
GycoFi, Inc. |
Expression of class 2 mannosidase and class III mannosidase in lower eukaryotic cells
|
|
US8697394B2
(en)
*
|
2000-06-28 |
2014-04-15 |
Glycofi, Inc. |
Production of modified glycoproteins having multiple antennary structures
|
|
US20060034828A1
(en)
*
|
2000-06-28 |
2006-02-16 |
Gerngross Tillman U |
Immunoglobulins comprising predominantly a GlcNAcMAN5GLCNAC2 glycoform
|
|
CA2471551C
(en)
*
|
2001-12-27 |
2014-09-30 |
Glycofi, Inc. |
Methods to engineer mammalian-type carbohydrate structures
|
|
US20060024292A1
(en)
*
|
2001-12-27 |
2006-02-02 |
Gerngross Tillman U |
Immunoglobulins comprising predominantly a Gal2GlcNAc2Man3GlcNAc2 glycoform
|
|
US20060034829A1
(en)
*
|
2001-12-27 |
2006-02-16 |
Gerngross Tillman U |
Immunoglobulins comprising predominantly a MAN3GLCNAC2 glycoform
|
|
US6964784B2
(en)
*
|
2002-03-07 |
2005-11-15 |
Optigenex, Inc. |
Method of preparation and composition of a water soluble extract of the bioactive component of the plant species uncaria for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals
|
|
US7332299B2
(en)
|
2003-02-20 |
2008-02-19 |
Glycofi, Inc. |
Endomannosidases in the modification of glycoproteins in eukaryotes
|
|
CA2558635A1
(en)
*
|
2004-03-17 |
2005-09-29 |
Glycofi, Inc. |
Method of engineering a cytidine monophosphate-sialic acid synthetic pathway in fungi and yeast
|
|
JP5752582B2
(ja)
*
|
2004-04-29 |
2015-07-22 |
グライコフィ， インコーポレイテッド |
糖タンパク質の作製においてアルファ−マンノシダーゼ抵抗性グリカンを減少させるか又は排除する方法
|
|
EP1942935A4
(en)
*
|
2005-09-02 |
2009-12-23 |
Glycofi Inc |
IMMUNOGLOBULINS CONTAINING PRESENTLY A GLCNACMAN3GLCNAC2 GLYCOFORM
|
|
AU2005336263A1
(en)
*
|
2005-09-09 |
2007-03-15 |
Glycofi, Inc. |
Immunoglobulin comprising predominantly a man7GlcNAc2, Man8GlcNAc2 glycoform
|
|
EP1954815B1
(en)
*
|
2005-11-15 |
2015-02-25 |
GlycoFi, Inc. |
Production of glycoproteins with reduced o-glycosylation
|
|
EP2022855B1
(en)
*
|
2006-05-16 |
2015-08-19 |
Daiichi Sankyo Company, Limited |
High secretion production method of protein
|
|
CA2651456A1
(en)
*
|
2006-05-19 |
2007-11-29 |
Glycofi, Inc. |
Recombinant vectors
|
|
KR20090130029A
(ko)
*
|
2007-03-07 |
2009-12-17 |
글리코파이, 인크. |
푸코실화가 변형된 당단백질의 제조
|
|
JP5967861B2
(ja)
|
2007-04-03 |
2016-08-10 |
オキシレイン ユーケー リミテッド |
分子のグリコシル化
|
|
US8637435B2
(en)
*
|
2007-11-16 |
2014-01-28 |
Merck Sharp & Dohme Corp. |
Eukaryotic cell display systems
|
|
WO2009089154A2
(en)
*
|
2008-01-03 |
2009-07-16 |
Cornell Research Foundation, Inc. |
Glycosylated protein expression in prokaryotes
|
|
JP2011514157A
(ja)
|
2008-02-20 |
2011-05-06 |
グライコフィ， インコーポレイテッド |
蛋白質生産用ベクター及び酵母株
|
|
CA2715212A1
(en)
|
2008-03-03 |
2009-09-11 |
Glycofi, Inc. |
Surface display of recombinant proteins in lower eukaryotes
|
|
MX2010013059A
(es)
|
2008-05-30 |
2010-12-20 |
Glycofi Inc |
Cepa de levadura para la produccion de proteinas con galactosa alfa-1,3-enlazada terminal.
|
|
US8067339B2
(en)
*
|
2008-07-09 |
2011-11-29 |
Merck Sharp & Dohme Corp. |
Surface display of whole antibodies in eukaryotes
|
|
WO2010019487A1
(en)
|
2008-08-12 |
2010-02-18 |
Glycofi, Inc. |
Improved vectors and yeast strains for protein production: ca2+ atpase overexpression
|
|
EP2401378B1
(en)
|
2009-02-25 |
2013-08-14 |
Merck Sharp & Dohme Corp. |
Metabolic engineering of a galactose assimilation pathway in the glycoengineered yeast pichia pastoris
|
|
KR102000383B1
(ko)
|
2009-09-29 |
2019-07-15 |
유니버시테이트 젠트 |
만노스-1-포스포-6-만노스 결합의 포스포-6-만노스로의 가수분해
|
|
JP2013507921A
(ja)
*
|
2009-10-16 |
2013-03-07 |
メルク・シャープ・エンド・ドーム・コーポレイション |
宿主細胞抗原に対する抗体に対する検出可能な交差結合活性を欠くタンパク質の、ピチア・パストリスにおける製造方法
|
|
JP2013509180A
(ja)
|
2009-10-30 |
2013-03-14 |
メルク・シャープ・エンド・ドーム・コーポレイション |
改善された分泌効率を有する組換えタンパク質の産生方法
|
|
CN102725396A
(zh)
|
2009-10-30 |
2012-10-10 |
默沙东公司 |
在缺乏二肽基氨肽酶活性的巴斯德毕赤酵母中生产治疗性蛋白的方法
|
|
US20130053550A1
(en)
|
2009-11-19 |
2013-02-28 |
Oxyrane Uk Limited |
Yeast strains producing mammalian-like complex n-glycans
|
|
BR112012020882A2
(pt)
|
2010-02-24 |
2015-11-03 |
Merck Sharp & Dohme |
métodos para produzir uma glicoproteína heteróloga e para produzir uma composição de glicoproteína, célula hospedeira, composição de glicoproteína, e, uso da pichia pastoris recombinante.
|
|
AU2011258425B2
(en)
|
2010-05-27 |
2015-12-10 |
Merck Sharp & Dohme Llc |
Method for preparing antibodies having improved properties
|
|
JP6131190B2
(ja)
|
2010-09-29 |
2017-05-17 |
オキシレイン ユーケー リミテッド |
リン酸化ｎ−グリカンの脱マンノシル化
|
|
BR112013007616B1
(pt)
|
2010-09-29 |
2023-01-24 |
Oxyrane Uk Limited |
Métodos para retirar o cap ("uncapping") de porções de manose-1- fosfo-6-manose e desmanosilar n-glicanos fosforilados em uma glicoproteína, para direcionar uma glicoproteína para o interior de uma célula de mamífero, e para converter uma glicoproteína de uma primeira forma que não se liga substancialmente a um receptor de manose-6-fosfato em uma segunda forma que se liga substancialmente a um receptor de manose-6-fosfato em uma célula de mamífero
|
|
US9365846B2
(en)
|
2010-12-01 |
2016-06-14 |
Merck Sharp & Dohme Corp. |
Surface, anchored Fc-bait antibody display system
|
|
WO2012115903A2
(en)
|
2011-02-25 |
2012-08-30 |
Merck Sharp & Dohme Corp. |
Yeast strain for the production of proteins with modified o-glycosylation
|
|
WO2012145666A1
(en)
*
|
2011-04-21 |
2012-10-26 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Peptide and conjugate vaccines for fungal infections
|
|
AU2012258907A1
(en)
|
2011-05-25 |
2013-11-07 |
Merck Sharp & Dohme Corp. |
Method for preparing Fc-containing polypeptides having improved properties
|
|
WO2013062940A1
(en)
|
2011-10-28 |
2013-05-02 |
Merck Sharp & Dohme Corp. |
Engineered lower eukaryotic host strains for recombinant protein expression
|
|
CA2867237C
(en)
|
2012-03-15 |
2024-01-02 |
Wouter Vervecken |
Methods and materials for treatment of pompe's disease
|
|
CN104271816A
(zh)
|
2012-05-11 |
2015-01-07 |
默沙东公司 |
表面锚定的轻链诱饵抗体展示系统
|
|
DK2852610T3
(en)
|
2012-05-23 |
2018-09-03 |
Glykos Finland Oy |
PRODUCTION OF FUCOSYLED GLYCOPROTEIN
|
|
AU2013335065B2
(en)
|
2012-10-22 |
2018-10-25 |
Merck Sharp & Dohme Llc |
CRZ1 mutant fungal cells
|
|
EP2925345B1
(en)
|
2012-12-03 |
2018-09-05 |
Merck Sharp & Dohme Corp. |
Method for making o-glycosylated carboxy terminal portion (ctp) peptide-based insulin and insulin analogues
|
|
AU2013363266A1
(en)
*
|
2012-12-17 |
2015-05-07 |
Merck Sharp & Dohme Corp. |
pmt2, och1, pmt5 Mutant Cells
|
|
AU2015293949B2
(en)
|
2014-07-21 |
2019-07-25 |
Teknologian Tutkimuskeskus Vtt Oy |
Production of glycoproteins with mammalian-like N-glycans in filamentous fungi
|
|
WO2017117539A1
(en)
|
2015-12-30 |
2017-07-06 |
Northwestern University |
Cell-free glycoprotein synthesis (cfgps) in prokaryotic cell lysates enriched with components for glycosylation
|
|
CN105671021B
(zh)
*
|
2016-03-01 |
2019-06-28 |
山东大学 |
甘露糖苷酶i的表达基因的应用
|
|
US10829795B2
(en)
|
2016-07-14 |
2020-11-10 |
Northwestern University |
Method for rapid in vitro synthesis of glycoproteins via recombinant production of N-glycosylated proteins in prokaryotic cell lysates
|
|
US11898187B2
(en)
|
2017-08-15 |
2024-02-13 |
Northwestern University |
Protein glycosylation sites by rapid expression and characterization of N-glycosyltransferases
|
|
US11530432B2
(en)
|
2018-03-19 |
2022-12-20 |
Northwestern University |
Compositions and methods for rapid in vitro synthesis of bioconjugate vaccines in vitro via production and N-glycosylation of protein carriers in detoxified prokaryotic cell lysates
|
|
WO2019204346A1
(en)
|
2018-04-16 |
2019-10-24 |
Northwestern University |
METHODS FOR CO-ACTIVATING IN VITRO NON-STANDARD AMINO ACID (nsAA) INCORPORATION AND GLYCOSYLATION IN CRUDE CELLLYSATES
|
|
WO2020072127A2
(en)
|
2018-08-03 |
2020-04-09 |
Northwestern University |
On demand, portable, cell-free molecular sensing platform
|
|
EP3908669A4
(en)
|
2019-01-11 |
2023-05-03 |
Northwestern University |
SYNTHESIS OF BIOCONJUGATED VACCINES IN PROKARYOT CELL LYSATE
|
|
US12325884B2
(en)
|
2019-03-04 |
2025-06-10 |
Northwestern University |
Riboswitch-based fluoride sensing in cell-free extract
|
|
US12226410B2
(en)
|
2019-10-18 |
2025-02-18 |
Northwestern University |
Methods for enhancing cellular clearance of pathological molecules via activation of the cellular protein ykt6
|
|
WO2021081485A1
(en)
|
2019-10-25 |
2021-04-29 |
Northwestern University |
Cell-free extract preparation protocol for enrichment of membrane vesicles and increased glycoprotein yields
|
|
CN114645029B
(zh)
*
|
2022-03-11 |
2024-09-10 |
上海交通大学 |
分离人工合成的MpgS蛋白质多肽和MpgP蛋白质多肽及其应用
|